CURX logo

CURX Curanex Pharmaceuticals Inc

$4.86
$0.29
(6.52%)
Today
Closed $4.74
$0.1212
(2.56%)
After Hours
42

Bearish Sentiment

How do you feel about CURX?

Loading...
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of...
PR Newswire
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)
Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) Wolf Haldenstein Adler...
PR Newswire
Rosen Law Firm Encourages Curanex Pharmaceuticals Inc. Investors to Inquire About Securities Class Action Investigation CURX
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX) resulting...
Business Wire
What's Behind Curanex Pharmaceuticals (CURX) 56% Surge After Hours
Curanex Pharmaceuticals shares surged in after-hours trading after the company completed a GMP-compliant batch supporting its planned IND submission for ulcerative colitis. read more...
Benzinga